ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels will re-open on 14-08-2020 at 9:00 CET. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Acacia Pharma, ISIN GB00BYWF9Y76, on Euronext Brussels is suspended on the request of the company from 13/08/2020 at 14:45 CET until the publication of a press release. […]
This Communication (FSMA_2020_09; available in French or Dutch only; annex available in English) addresses the guidelines drawn up by the European Securities and Markets Authority (ESMA) regarding the stress test scenarios based on the EU’s Money Market Funds Regulation, and on the implementation of those guidelines by the FSMA. Source: FSMA
The Financial Services and Markets Authority (FSMA) warns the public against the activities of the website named www.ucm-limited.com, which offers investment services without complying with Belgian financial legislation. This ‘company’ is not authorized to provide investment services in or from Belgium. Moreover, the offer made via that website shows numerous indications of fraud and seems to be similar to […]
In the past few weeks, the FSMA has received new complaints from consumers who have been approached by companies offering wealth management and/or savings plans, most often with a guaranteed return. The FSMA warns consumers against these tempting offers, because often behind them are fraudsters who are not authorized to make such offers, the sole […]
This press release is not available in English. Please consult the French or Dutch page. Source: FSMA